Hybio Pharmaceutical (300199.SZ): HY3003 Injection's Investigational New Drug application accepted by the U.S. FDA

Zhito Finance APP News: Hybio Pharmaceutical (300199.SZ) announced that the company recently received a clinical trial application acceptance notice from the U.S. Food and Drug Administration (FDA) regarding HY3003 injection.